相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dose Finding Study for the Use of Subcutaneous Recombinant Interleukin-2 to Augment Natural Killer Cell Numbers in an Outpatient Setting for Stage 4 Neuroblastoma After Megatherapy and Autologous Stem-Cell Reinfusion
Ruth Ladenstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Neuroblastoma Progression Correlates with Downregulation of the Lymphangiogenesis Inhibitor sVEGFR-2
Juergen Becker et al.
CLINICAL CANCER RESEARCH (2010)
Transient depletion of CD4+ T cells augments IL-21-based immunotherapy of disseminated neuroblastoma in syngeneic mice
Michela Croce et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
Suzanne Shusterman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Interferon-β induces apoptosis in human SH-SY5Y neuroblastoma cells through activation of JAK-STAT signaling and down-regulation of PI3K/Akt pathway
Simona Dedoni et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Interleukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells
Tasnim Ara et al.
CANCER RESEARCH (2009)
Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients
Lorena Passoni et al.
CANCER RESEARCH (2009)
Interferon-γ-Dependent Infiltration of Human T Cells into Neuroblastoma Tumors In vivo
Gregor S. D. Reid et al.
CLINICAL CANCER RESEARCH (2009)
Increased Intratumoral FOXP3-positive Regulatory Immune Cells during Interleukin-2 Treatment in Metastatic Renal Cell Carcinoma
Hanne Krogh Jensen et al.
CLINICAL CANCER RESEARCH (2009)
Prognostic Significance of Interleukin-6 Single Nucleotide Polymorphism Genotypes in Neuroblastoma: rs1800795 (Promoter) and rs8192284 (Receptor)
Joanne P. Lagmay et al.
CLINICAL CANCER RESEARCH (2009)
HIF-1α and HIF-2α Are Differentially Regulated In vivo in Neuroblastoma: High HIF-1α Correlates Negatively to Advanced Clinical Stage and Tumor Vascularization
Rosa Noguera et al.
CLINICAL CANCER RESEARCH (2009)
Anti-IL-10 antibody improves the therapeutic efficacy of targeted liposomal oligonucleotides
Chiara Brignole et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
Rosalba Salcedo et al.
JOURNAL OF IMMUNOLOGY (2009)
CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation
Alex J. Carlisle et al.
MOLECULAR CANCER (2009)
New insights into the regulation of T cells by γc family cytokines
Yrina Rochman et al.
NATURE REVIEWS IMMUNOLOGY (2009)
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
Helena Caren et al.
BIOCHEMICAL JOURNAL (2008)
Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen
Michela Croce et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Plasma midkine level is a prognostic factor for human neuroblastoma
Shinya Ikematsu et al.
CANCER SCIENCE (2008)
Interleukin-6 and Soluble Interleukin-6 Receptor Levels as Markers of Disease Extent and Prognosis in Neuroblastoma
Rachel A. Egler et al.
CLINICAL CANCER RESEARCH (2008)
Identification of galectin-3-binding protein as a factor secreted by tumor cells that stimulates interleukin-6 expression in the bone marrow stroma
Yasushi Fukaya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo
Qiang Zhou et al.
JOURNAL OF IMMUNOLOGY (2008)
IFN-β sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression
Shannon F. Rosati et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al.
NATURE (2008)
Oncogenic mutations of ALK kinase in neuroblastoma
Yuyan Chen et al.
NATURE (2008)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
Molecular origins of cancer: Tumor angiogenesis
Robert S. Kerbel
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
Midkine is highly expressed in neuroblastoma tissues
Henning C. Fiegel et al.
PEDIATRIC SURGERY INTERNATIONAL (2008)
Interleukin-6 and its receptor in cancer - Implications for translational therapeutics
David S. Hong et al.
CANCER (2007)
The Chemokine Receptor CXCR4 Strongly Promotes Neuroblastoma Primary Tumour and Metastatic Growth, but not Invasion
Roland Meier et al.
PLOS ONE (2007)
Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells
Yan Zeng et al.
CANCER RESEARCH (2007)
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma
Liping Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma
Libo Zhang et al.
NEOPLASIA (2007)
Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma:: HIF-2α promotes an aggressive phenotype
Linda Holmquist-Mengelbier et al.
CANCER CELL (2006)
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S. Fulda et al.
ONCOGENE (2006)
Angiogenesis in a human neuroblastoma xenograft model:: mechanisms and inhibition by tumour-derived interferon-γ
D. Ribatti et al.
BRITISH JOURNAL OF CANCER (2006)
Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma
Y. Ren et al.
ONCOGENE (2006)
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: A study of the Children's Oncology Group
KL Osenga et al.
CLINICAL CANCER RESEARCH (2006)
Superior protective and therapeutic effects of IL-12 and IL-18 gene-transduced dendritic neuroblastoma fusion cells on liver metastasis of murine neuroblastoma
Hisae Iinuma et al.
JOURNAL OF IMMUNOLOGY (2006)
Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastoma
T Khan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
CXCL12 does not attract CXCR4(+) human metastatic neuroblastoma cells: Clinical implications
I Airoldi et al.
CLINICAL CANCER RESEARCH (2006)
Combination immunotherapy with clinical-scale enriched human γδ T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma
M Otto et al.
CLINICAL CANCER RESEARCH (2005)
Adeno-associated virus vector-mediated systemic delivery of IFN-β combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models
CJ Streck et al.
CLINICAL CANCER RESEARCH (2005)
Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications
L Raffaghello et al.
ONCOGENE (2005)
Interferon γ induces neurite outgrowth by up-regulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of ERK1/2 pathway
JH Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Interferon-γ induces caspase-8 in neuroblastomas without affecting methylation of caspase-8 promoter
S Kim et al.
JOURNAL OF PEDIATRIC SURGERY (2004)
Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression
K Beppu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Restriction of neuroblastoma angiogenesis and growth by interferon-α/β
CJ Streck et al.
SURGERY (2004)
IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors:: Role for CD8+ T cells
R Salcedo et al.
JOURNAL OF IMMUNOLOGY (2004)
Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma
Y Ren et al.
ONCOGENE (2004)
CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases
HV Russell et al.
JOURNAL OF PEDIATRIC SURGERY (2004)
Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2
LS Metelitsa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Different levels of control prevent interferon-γ-inducible HLA-class II expression in human neuroblastoma cells
M Croce et al.
ONCOGENE (2003)
Adoptive-cell-transfer therapy for the treatment of patients with cancer
ME Dudley et al.
NATURE REVIEWS CANCER (2003)
c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571
R Vitali et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The regulation of angiogenesis in neuroblastoma
A Chlenski et al.
CANCER LETTERS (2003)
Expression of costimulatory molecules in human neuroblastoma. Evidence that CD40+neuroblastoma cells undergo apoptosis following interaction with CD40L
I Airoldi et al.
BRITISH JOURNAL OF CANCER (2003)
Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma
RF Rousseau et al.
BLOOD (2003)
The IL-12 family of heterodimeric cytokines: New players in the regulation of T cell responses
G Trinchieri et al.
IMMUNITY (2003)
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody
AP Vicari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
N-myc oncogene overexpression down-regulates leukemia inhibitory factor in neuroblastoma
E Hatzi et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway
S Fulda et al.
ONCOGENE (2002)
Angiogenesis and anti-angiogenesis in neuroblastoma
D Ribatti et al.
EUROPEAN JOURNAL OF CANCER (2002)
Phase II trial of the anti-GD2 monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma
BH Kushner et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Interferon-γ cooperates with retinoic acid and phorbol ester to induce differentiation and growth inhibition of human neuroblastoma cells
I Guzhova et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
IFN-γ-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy
U Pertl et al.
JOURNAL OF IMMUNOLOGY (2001)
Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression
MV Corrias et al.
TISSUE ANTIGENS (2001)
分享论文
